ASLTY (Asymchem Laboratories Tianjin Co) ROE % Adjusted to Book Value: 4.97% (As of Mar. 2026)


ASLTY Asymchem Laboratories Tianjin Co Ltd ASLTY
72 GF Score
Price $6.37
GF Value $4.52
Valuation Significantly Overvalued
! 10 Warning Signs
View Full Analysis

What is Asymchem Laboratories Tianjin Co ROE % Adjusted to Book Value?

Asymchem Laboratories Tianjin Co ASLTY 72 ROE % Adjusted to Book Value is 4.97% as of Mar. 2026. GuruFocus rates ASLTY with a GF Score™ of 72/100 and a GF Value™ of $4.52 (Significantly Overvalued). The stock has 10 warning signs investors should review.

Asymchem Laboratories Tianjin Co's ROE % for the quarter that ended in Mar. 2026 was 6.91%. Asymchem Laboratories Tianjin Co's PB Ratio for the quarter that ended in Mar. 2026 was 1.39. Asymchem Laboratories Tianjin Co's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2026 was 4.97%.


Asymchem Laboratories Tianjin Co ROE % Adjusted to Book Value Related Terms


Asymchem Laboratories Tianjin Co ROE % Adjusted to Book Value Historical Data

* Premium members only.

The historical data trend for Asymchem Laboratories Tianjin Co's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Asymchem Laboratories Tianjin Co ROE % Adjusted to Book Value Chart

Asymchem Laboratories Tianjin Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROE % Adjusted to Book Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 5.36 7.26

Asymchem Laboratories Tianjin Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.94 7.03 4.48 8.30 4.97

ASLTY vs VRTX, REGN, ALNY: ROE % Adjusted to Book Value Comparison

For the Biotechnology subindustry, Asymchem Laboratories Tianjin Co's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Asymchem Laboratories Tianjin Co ROE % Adjusted to Book Value vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Asymchem Laboratories Tianjin Co's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Asymchem Laboratories Tianjin Co's ROE % Adjusted to Book Value falls into.


ASLTY
72GF Score
Asymchem Laboratories Tianjin Co Ltd ASLTY
ROE % Adjusted to Book Value is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Asymchem Laboratories Tianjin Co ROE % Adjusted to Book Value Calculation

Asymchem Laboratories Tianjin Co's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2025 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=6.68% / 0.92
=7.26%

Asymchem Laboratories Tianjin Co's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2026 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=6.91% / 1.39
=4.97%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a ROE % Adjusted to Book Value of 4.97% mean?
Asymchem Laboratories Tianjin Co (ASLTY) has a ROE % Adjusted to Book Value of 4.97% as of Mar. 2026. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Asymchem Laboratories Tianjin Co and its competitors.
Is Asymchem Laboratories Tianjin Co's ROE % Adjusted to Book Value too high?
Asymchem Laboratories Tianjin Co's current ROE % Adjusted to Book Value is 4.97%. Overall, Asymchem Laboratories Tianjin Co has a GF Score™ of 72/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Asymchem Laboratories Tianjin Co's ROE % Adjusted to Book Value compare to VRTX and REGN?
Asymchem Laboratories Tianjin Co's ROE % Adjusted to Book Value of 4.97% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % Adjusted to Book Value for a Biotechnology company?
A good ROE % Adjusted to Book Value depends on the Biotechnology industry context. However, ROE % Adjusted to Book Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % Adjusted to Book Value mean?
A high ROE % Adjusted to Book Value can signal that a stock is expensive relative to its fundamentals. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Asymchem Laboratories Tianjin Co and its competitors. Asymchem Laboratories Tianjin Co's current ROE % Adjusted to Book Value is 4.97%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Asymchem Laboratories Tianjin Co stock overvalued right now?
Based on GuruFocus' analysis, Asymchem Laboratories Tianjin Co (ASLTY) is currently considered Significantly Overvalued. The stock's GF Value™ is $4.52, compared to a current price of $6.37 — trading 40.9% above its estimated fair value. The current ROE % Adjusted to Book Value is 4.97%. Asymchem Laboratories Tianjin Co's overall GF Score™ is 72/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % Adjusted to Book Value calculated?
ROE % Adjusted to Book Value is calculated from a company's financial statements. For Asymchem Laboratories Tianjin Co (ASLTY), the current ROE % Adjusted to Book Value is 4.97% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Asymchem Laboratories Tianjin Co (ASLTY) Overvalued in 2026?

Based on GuruFocus' analysis, Asymchem Laboratories Tianjin Co stock appears to be overvalued. The current stock price of $6.37 is trading 40.9% above its estimated GF Value™ of $4.52. GuruFocus considers Asymchem Laboratories Tianjin Co to be Significantly Overvalued.

Key valuation signals for ASLTY:

  • ROE % Adjusted to Book Value: 4.97%
  • GF Value™: $4.52 vs. price of $6.37 (40.9% above fair value)
  • GF Score™: 72/100 with 10 warning signs

No single metric tells the full story. See the ASLTY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Asymchem Laboratories Tianjin Co Business Description

Other Exchanges 06821:Hong Kong002821:China
Address No. 6 Dongting 3rd Street, Economic and Technological Development Zone, Tianjin, CHN, 300457
Asymchem Laboratories Tianjin Co Ltd is a China-based company, a technology-driven provider of Contract Development and manufacturing organization solutions throughout the drug development and manufacturing process. The group provides clinical-stage CDMO solutions, commercial-stage CDMO solutions, and emerging services. Its operations relate to contract development and manufacturing, which focus on innovation and commercial application of pharmaceutical technology. It has geographic areas in the Chinese Mainland and Overseas.
72GF Score

Get the complete analysis for ASLTY

ROE % Adjusted to Book Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$6.37
Price
$4.52
GF Value